How to Approve ‘Biosimilar’ Drugs? The FDA Has to Figure That Out
Unlike generics, which are the exact chemical copies of a brand-name drug, biosimilars have large and often complex proteins that are made in living cells, and tiny differences can play havoc with the product. It may take years…